These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23273245)

  • 1. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.
    Serrano B; Alemany L; Tous S; Bruni L; Clifford GM; Weiss T; Bosch FX; de Sanjosé S
    Infect Agent Cancer; 2012 Dec; 7(1):38. PubMed ID: 23273245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).
    Serrano B; Alemany L; Ruiz PA; Tous S; Lima MA; Bruni L; Jain A; Clifford GM; Qiao YL; Weiss T; Bosch FX; de Sanjosé S
    Cancer Epidemiol; 2014 Dec; 38(6):748-56. PubMed ID: 25305098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.
    Hartwig S; St Guily JL; Dominiak-Felden G; Alemany L; de Sanjosé S
    Infect Agent Cancer; 2017; 12():19. PubMed ID: 28400857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
    Aljunid S; Zafar A; Saperi S; Amrizal M
    Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
    Alemany L; de Sanjosé S; Tous S; Quint W; Vallejos C; Shin HR; Bravo LE; Alonso P; Lima MA; Guimerà N; Klaustermeier J; Llombart-Bosch A; Kasamatsu E; Tatti SA; Felix A; Molina C; Velasco J; Lloveras B; Clavero O; Lerma E; Laco J; Bravo IG; Guarch R; Pelayo A; Ordi J; Andújar M; Sanchez GI; Castellsagué X; Muñoz N; Bosch FX;
    Int J Cancer; 2014 Jul; 135(1):88-95. PubMed ID: 24382655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical adenocarcinoma: moving towards better prevention.
    Seoud M; Tjalma WA; Ronsse V
    Vaccine; 2011 Nov; 29(49):9148-58. PubMed ID: 21983356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination.
    Bhatla N; Lal N; Bao YP; Ng T; Qiao YL
    Vaccine; 2008 Jun; 26(23):2811-7. PubMed ID: 18450340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
    Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
    Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.
    Vänskä S; Luostarinen T; Lagheden C; Eklund C; Kleppe SN; Andrae B; Sparén P; Sundström K; Lehtinen M; Dillner J
    Am J Epidemiol; 2021 Apr; 190(4):506-514. PubMed ID: 32639531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
    Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
    J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
    Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
    Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
    BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
    Alemany L; Pérez C; Tous S; Llombart-Bosch A; Lloveras B; Lerma E; Guarch R; Andújar M; Pelayo A; Alejo M; Ordi J; Klaustermeier J; Velasco J; Guimerà N; Clavero O; Castellsagué X; Quint W; Muñoz N; Bosch FX; de Sanjosé S;
    Gynecol Oncol; 2012 Mar; 124(3):512-7. PubMed ID: 22119990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
    Giuliano AR; Joura EA; Garland SM; Huh WK; Iversen OE; Kjaer SK; Ferenczy A; Kurman RJ; Ronnett BM; Stoler MH; Bautista OM; Moeller E; Ritter M; Shields C; Luxembourg A
    Gynecol Oncol; 2019 Jul; 154(1):110-117. PubMed ID: 30982556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan.
    Sakamoto J; Kamiura S; Okayama K; Okodo M; Shibata T; Osaka Y; Fujita S; Takata E; Takagi H; Takakura M; Sasagawa T
    Papillomavirus Res; 2018 Dec; 6():46-51. PubMed ID: 30401640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
    Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.